Related references
Note: Only part of the references are listed.Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic revaccinations
Marton Konig et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2023)
B Cell Depletion and SARS-CoV-2 Vaccine Responses in Neuroimmunologic Patients
Barbara Kornek et al.
ANNALS OF NEUROLOGY (2022)
COVID-19 Vaccine Response in People with Multiple Sclerosis
Emma C. Tallantyre et al.
ANNALS OF NEUROLOGY (2022)
Humoral- and T-Cell Specific Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients With MS Using Different Disease-Modifying Therapies
Carla Tortorella et al.
NEUROLOGY (2022)
Immunogenicity and safety of mRNA COVID-19 vaccines in people with multiple sclerosis treated with different disease-modifying therapies
Fioravante Capone et al.
NEUROTHERAPEUTICS (2022)
First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine
Joachim Havla et al.
JOURNAL OF NEUROLOGY (2022)
mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis
Massimiliano Di Filippo et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2022)
Vaccination and immunotherapies in neuroimmunological diseases
Alexander Winkelmann et al.
NATURE REVIEWS NEUROLOGY (2022)
Varicella zoster virus and influenza vaccine antibody titres in patients from MAGNIFY-MS who were treated with cladribine tablets for highly active relapsing multiple sclerosis
Klaus Schmierer et al.
MULTIPLE SCLEROSIS JOURNAL (2022)
Multiple sclerosis relapse after COVID-19 vaccination: A case report-based systematic review
Fardin Nabizadeh et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2022)
Recommendations for vaccination in patients with multiple sclerosis who are eligible for immunosuppressive therapies: Spanish consensus statement
S. Otero-Romero et al.
NEUROLOGIA (2021)
Humoral and cellular responses to mRNA vaccines against SARS-CoV-2 in patients with a history of CD20 B-cell-depleting therapy (RituxiVac): an investigator-initiated, single-centre, open-label study
Matthias B. Moor et al.
LANCET RHEUMATOLOGY (2021)
Vaccinations in patients with multiple sclerosis: A Delphi consensus statement
Agostino Riva et al.
MULTIPLE SCLEROSIS JOURNAL (2021)
Incidence, risk factors and impact of seasonal influenza in pregnancy: A national cohort study
Nicola Vousden et al.
PLOS ONE (2021)
Humoral immune response in multiple sclerosis patients following PfizerBNT162b2 COVID19 vaccination: Up to 6 months cross-sectional study
Anat Achiron et al.
JOURNAL OF NEUROIMMUNOLOGY (2021)
T cells step up after SARS-CoV-2 vaccination with B cell depletion
Thomas Berger et al.
NATURE REVIEWS NEUROLOGY (2021)
Vaccines for older adults
Anthony L. Cunningham et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
T-cell responses to SARS-CoV-2 in multiple sclerosis patients treated with ocrelizumab healed from COVID-19 with absent or low anti-spike antibody titers
Marco Iannetta et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2021)
Effect of Different Disease-Modifying Therapies on Humoral Response to BNT162b2 Vaccine in Sardinian Multiple Sclerosis Patients
Maristella Pitzalis et al.
FRONTIERS IN IMMUNOLOGY (2021)
Discordant humoral and T cell immune responses to SARS-CoV-2 vaccination in people with multiple sclerosis on anti-CD20 therapy
Sachin P. Gadani et al.
EBIOMEDICINE (2021)
Humoral Immune Response after the Third SARS-CoV-2 mRNA Vaccination in CD20 Depleted People with Multiple Sclerosis
Lutz Achtnichts et al.
VACCINES (2021)
Disease-modifying therapies and SARS-CoV-2 vaccination in multiple sclerosis: an expert consensus
Diego Centonze et al.
JOURNAL OF NEUROLOGY (2021)
Multiple sclerosis: Is there a risk of worsening after yellow fever vaccination?
Caroline Papeix et al.
MULTIPLE SCLEROSIS JOURNAL (2021)
Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy
Sokratis A. Apostolidis et al.
NATURE MEDICINE (2021)
Association of Disease-Modifying Treatment and Anti-CD20 Infusion Timing With Humoral Response to 2 SARS-CoV-2 Vaccines in Patients With Multiple Sclerosis
Giulio Disanto et al.
JAMA NEUROLOGY (2021)
Humoral and T-Cell Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Ocrelizumab
Livnat Brill et al.
JAMA NEUROLOGY (2021)
Rabies vaccination and multiple sclerosis relapse: A retrospective cohort study
Angela Huttner et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2021)
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies
Maria Pia Sormani et al.
EBIOMEDICINE (2021)
Multiple Sclerosis, Disease-Modifying Therapies and COVID-19: A Systematic Review on Immune Response and Vaccination Recommendations
Veronica Cabreira et al.
VACCINES (2021)
Vaccine response following anti-CD20 therapy: a systematic review and meta-analysis of 905 patients
Abi Vijenthira et al.
BLOOD ADVANCES (2021)
Humoral immune response and lymphocyte levels after complete vaccination against COVID-19 in a cohort of multiple sclerosis patients treated with cladribine tablets
Christoph Grothe et al.
JOURNAL OF CENTRAL NERVOUS SYSTEM DISEASE (2021)
Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies
Anat Achiron et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2021)
2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases
Victoria Furer et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Tick-borne encephalitis vaccination in multiple sclerosis A prospective, multicenter study
Alexander Winkelmann et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2020)
Why vaccines matter: understanding the broader health, economic, and child development benefits of routine vaccination
Arindam Nandi et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)
Risk of MS relapse after yellow fever vaccination A self-controlled case series
Angela Huttner et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2020)
Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis The VELOCE study
Amit Bar-Or et al.
NEUROLOGY (2020)
Effects of MS disease-modifying therapies on responses to vaccinations: A review
John Robert Ciotti et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Protecting people with multiple sclerosis through vaccination
Saul Reyes et al.
PRACTICAL NEUROLOGY (2020)
Immunogenicity and predictors of response to a single dose trivalent seasonal influenza vaccine in multiple sclerosis patients receiving disease-modifying therapies
Christoph Metze et al.
CNS NEUROSCIENCE & THERAPEUTICS (2019)
Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7)
Catherine Cordonnier et al.
LANCET INFECTIOUS DISEASES (2019)
Epidemiology and treatment of multiple sclerosis in elderly populations
Caila B. Vaughn et al.
NATURE REVIEWS NEUROLOGY (2019)
Immunization and multiple sclerosis: Recommendations from the French multiple sclerosis society
Christine Lebrun et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
Pregnancy as a risk factor for severe influenza infection: an individual participant data meta-analysis
Dominik Mertz et al.
BMC INFECTIOUS DISEASES (2019)
Practice guideline update summary: Vaccine-preventable infections and immunization in multiple sclerosis Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology
Mauricio F. Farez et al.
NEUROLOGY (2019)
Vaccines for International Travel
David O. Freedman et al.
MAYO CLINIC PROCEEDINGS (2019)
Anti-CD20 therapy depletes activated myelin-specific CD8+ T cells in multiple sclerosis
Joseph J. Sabatino et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Vaccinations in Older Adults
Megan Burke et al.
CLINICS IN GERIATRIC MEDICINE (2018)
Antibody response to seasonal influenza vaccination in patients with multiple sclerosis receiving immunomodulatory therapy
H. K. Olberg et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
Influenza Vaccination, Pregnancy Safety, and Risk of Early Pregnancy Loss
Rhoda S. Sperling et al.
OBSTETRICS AND GYNECOLOGY (2018)
Human papillomavirus vaccine for children and adolescents
Marina I. Salvadori
PAEDIATRICS & CHILD HEALTH (2018)
Immune response to vaccines is maintained in patients treated with dimethyl fumarate
Christian von Hehn et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2018)
Impact of siponimod on vaccination response in a randomized, placebo-controlled study
Mike Ufer et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2017)
Is There a Consensus on Consensus Methodology? Descriptions and Recommendations for Future Consensus Research
Jane Waggoner et al.
ACADEMIC MEDICINE (2016)
Characteristics of Children and Adolescents With Multiple Sclerosis
Anita L. Belman et al.
PEDIATRICS (2016)
Pertussis vaccination in pregnancy
C. Mary Healy
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Randomized trial of vaccination in fingolimod-treated patients with multiple sclerosis
Ludwig Kappos et al.
NEUROLOGY (2015)
Vaccinations for Pregnant Women
Geeta K. Swamy et al.
OBSTETRICS AND GYNECOLOGY (2015)
Randomized study of teriflunomide effects on immune responses to neoantigen and recall antigens
Amit Bar-Or et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
Lorry G. Rubin et al.
CLINICAL INFECTIOUS DISEASES (2014)
Natalizumab treatment shows no clinically meaningful effects on immunization responses in patients with relapsing-remitting multiple sclerosis
Michael Kaufman et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2014)
Immunotherapies influence the influenza vaccination response in multiple sclerosis patients: an explorative study
Henning K. Olberg et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
Effects of Bacille Calmette-Guerin after the first demyelinating event in the CNS
Giovanni Ristori et al.
NEUROLOGY (2014)
AVIDITY OF VACCINE-INDUCED INFLUENZA IgG FAILS TO INCREASE IN FINGOLIMOD-TREATED PATIENTS WITH MS
Matthias Mehling et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2014)
Reduced antibody formation after influenza vaccination in patients with neuromyelitis optica spectrum disorder treated with rituximab
W. Kim et al.
EUROPEAN JOURNAL OF NEUROLOGY (2013)
Teriflunomide effect on immune response to influenza vaccine in patients with multiple sclerosis
Amit Bar-Or et al.
NEUROLOGY (2013)
Immune competence after alemtuzumab treatment of multiple sclerosis
Claire L. McCarthy et al.
NEUROLOGY (2013)
Preserved Antigen-Specific Immune Response in Patients with Multiple Sclerosis Responding to IFNβ-Therapy
Matthias Mehling et al.
PLOS ONE (2013)
Parents, adolescents, children and the human papillomavirus vaccine: a review
T. Walhart
INTERNATIONAL NURSING REVIEW (2012)
Pharmacodynamic Effects of Steady-State Fingolimod on Antibody Response in Healthy Volunteers: A 4-Week, Randomized, Placebo-Controlled, Parallel-Group, Multiple-Dose Study
Craig Boulton et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Seasonal and H1N1v influenza vaccines in MS: Safety and compliance
Eitan Auriel et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)
H1N1 vaccination does not increase risk of relapse in multiple sclerosis: a self-controlled case-series study
Mauricio F. Farez et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Vaccination against infection in patients with multiple sclerosis
Micha Loebermann et al.
NATURE REVIEWS NEUROLOGY (2012)
Humoral immune response to influenza vaccine in natalizumab-treated MS patients
Mattias Vagberg et al.
NEUROLOGICAL RESEARCH (2012)
Antigen-Specific Adaptive Immune Responses in Fingolimod-Treated Multiple Sclerosis Patients
Matthias Mehling et al.
ANNALS OF NEUROLOGY (2011)
Yellow Fever Vaccination and Increased Relapse Rate in Travelers With Multiple Sclerosis
Mauricio F. Farez et al.
ARCHIVES OF NEUROLOGY (2011)
Relapse risk in patients with multiple sclerosis after H1N1 vaccination, with or without seasonal influenza vaccination
Nuala McNicholas et al.
JOURNAL OF NEUROLOGY (2011)
Immunization Responses in Rheumatoid Arthritis Patients Treated With Rituximab Results From a Controlled Clinical Trial
Clifton O. Bingham et al.
ARTHRITIS AND RHEUMATISM (2010)
Correlates of Protection Induced by Vaccination
Stanley A. Plotkin
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Protective role of beta interferon in host defense against influenza A virus
Iris Koerner et al.
JOURNAL OF VIROLOGY (2007)
Immune response to influenza vaccine is maintained in patients with multiple sclerosis receiving interferon beta-1a
SR Schwid et al.
NEUROLOGY (2005)
Controlled trial of tick-borne encephalitis vaccination in patients with multiple sclerosis
U Baumhackl et al.
VACCINE (2003)
Immunization and MS - A summary of published evidence and recommendations
OT Rutschmann et al.
NEUROLOGY (2002)
Anti-viral properties of interferon beta treatment in patients with multiple sclerosis
J Hong et al.
MULTIPLE SCLEROSIS JOURNAL (2002)
Influenza vaccination in MS - Absence of T-cell response against white matter proteins
NF Moriabadi et al.
NEUROLOGY (2001)
Vaccinations and the risk of relapse in multiple sclerosis
C Confavreux et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)